ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±Å˳¬ÔÆ£©Âѳ²°©ÊÇÒ»ÖÖ³£¼ûµÄ¸¾¿ÆÖ×Áö£¬£¬£¬²¡ËÀÂÊÔÚ¸¾¿ÆÖ×ÁöÖÐÒ»Ö±¾ÓÓÚÊ×λ¡£»ùÓÚ²¬ÀàÒ©ÎïµÄ»¯ÁÆÊÇÂѳ²°©µÄÒ»ÏßÁÆ·¨¡£²¬ÀàÒ©ÎïÔçÆÚÁÆÐ§ÏÔÖø£¬£¬£¬µ«´ó¶¼»¼Õß×îÖÕ»áÒò¶Ô²¬ÀàÒ©ÎïµÄÄÍÒ©¶ø·ºÆðÖ×Áö¸´·¢¡£ÆÊÎöÂѳ²°©²¬ÄÍÒ©»úÖÆ¹ØÓÚÌá¸ßÂѳ²°©µÄÖÎÁÆË®Æ½¾ßÓÐÖ÷ÒªµÄÀíÂÛºÍÁÙ´²Êµ¼ùÒâÒå¡£Ò»Ö±ÒÔÀ´£¬£¬£¬Î§ÈÆ×ÅÒ©ÎïÔËÊä¡¢DNAËðÉËÐÞ¸´¡¢Ï¸°û´æ»îͨ·µ÷ÀíµÈ·½Ã棬£¬£¬Ñо¿Ö°Ô±¿ªÕ¹ÁË´ó×Ú¹ØÓÚÂѳ²°©²¬ÄÍÒ©µÄ»ù´¡Ñо¿£¬£¬£¬¼«´óµØÍØÕ¹Á˹ØÓÚÂѳ²°©²¬ÄÍÒ©µÄÊìϤ£¬£¬£¬¿ÉÊÇÏÖÔÚµÄÑо¿Ò²±£´æÁÙ´²×ª»¯Ç±Á¦È±·¦£¬£¬£¬»úÖÆÆÊÎö²»ÏµÍ³µÄÎÊÌâ¡£½øÒ»²½Ìù½üÁÙ´²²¢ÏµÍ³ÆÊÎö²¬ÄÍÒ©»úÖÆÊÇÂѳ²°©µÄÖ÷ÒªÑо¿Æ«Ïò¡£
¿ËÈÕ£¬£¬£¬ÖÐɽҽѧԺÉú»¯½ÌÑÐÊÒÅ˳¬ÔƸ±½ÌÊÚÍŶÓÔÚ¹ú¼ÊÖ×Áöѧ¾µäÆÚ¿¯ Oncogene (IF: 9.867) ÔÚÏß½ÒÏþÁËÌâΪ£º£º£ºROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancerµÄÑо¿ÂÛÎÄ¡£ÕâÊÇÅ˳¬ÔƸ±½ÌÊÚ¼Ì2019Äê6ÔºÍ2019Äê10ÔÂÔÚThe Journal of Clinical Investigation¡¢2021Äê8ÔÂÔÚNature Communications ½ÒÏþµÄ¹ØÓÚÂѳ²°©²¬ÄÍÒ©»úÖÆÑо¿µÄϵÁÐÎÄÕº󣬣¬£¬ÓÖÒ»Ñо¿Ð§¹û¡£
Å˳¬ÔƸ±½ÌÊÚÍŶÓʹÓÃÉÌÒµ»¯¼¤Ã¸ÒÖÖÆ¼Á¿â¶ÔÁÙ´²Ïà¹ØµÄ¼¤Ã¸°Ðµã¾ÙÐиßͨÁ¿Ë³²¬ºÏ³ÉÖÂËÀɸѡ£¬£¬£¬·¢Ã÷¸Æ/¸Æµ÷ÂѰ×ÒÀÀµÐÔÂѰ׼¤Ã¸ II (CAMKII)ÊÇÔö½øÂѳ²°©²¬ÄÍÒ©µÄÖ÷Òª¼¤Ã¸£¬£¬£¬ÒÖÖÆCAMKII¿ÉÏÔÖøÔöÇ¿Âѳ²°©¶Ô˳²¬µÄÃô¸ÐÐÔ¡£

ͼʾ£º£º£ºÍ¨Á¿Ë³²¬ºÏ³ÉÖÂËÀɸѡ·¢Ã÷CAMKII°Ðµã
Ñо¿ÍŶӶÔCAMKII Ôö½øÂѳ²°©²¬ÄÍÒ©µÄ»úÖÆ¾ÙÐÐϵͳÆÊÎö£¬£¬£¬·¢Ã÷£º£º£ºCAMKII ͬ¹¤Ã¸ CAMK2G ÔÚά³Ö˳²¬É±ÉËϵÄÂѳ²°©Ï¸°ûÄÚÑõ»¯»¹ÔÎÈ̬µÄµ÷¿ØÖÐʩչÖ÷Òª×÷Óã»CAMK2GÊDz¬ÄÍÒ©Âѳ²°©Ï¸°ûÄÚÖ÷ÒªµÄROS¸ÐÊÜÆ÷¡£Í¨¹ý´úлÆÊÎö¡¢ÖÊÆ×¡¢shRNAɸѡµÈʵÑ飬£¬£¬Ñо¿·¢Ã÷Âѳ²°©Ï¸°ûÄÚÔ´ÐÔµÄROSÉý¸ß²¢Ö±½ÓÑõ»¯ÐÞÊÎCAMK2G Met281/Met282 λµãµ¼ÖÂCAMK2GÆô¶¯¼¤»î£¨priming£©¡£Æô¶¯¼¤»îºóµÄCAMK2GÖ±½ÓÁ×ËữÏÂÓμ¤Ã¸ITPKB S174λµã¶øÔöÇ¿ITPKB¼¤Ã¸»îÐÔ£¬£¬£¬Ìá¸ßϸ°ûÄÚITPKBµÄ´úл²úÆ·Á×Ëἡ´¼IP4µÄˮƽ¡£¶ø¸ßˮƽµÄIP4ÏÔÖøÏÞÖÆÁË˳²¬ÓÕµ¼ÏµÄNOX4»îÐԵļ±¾çÉÏÉý£¬£¬£¬½µµÍNOX4±¬·¢µÄROSˮƽ£¬£¬£¬×èÖ¹ROSÓÕ·¢Æô¶¯Ï¸°ûµòÍö¡£¶øNOX4±¬·¢µÄµÍˮƽROS½øÒ»²½´Ì¼¤CAMK2G-pITPKB µÄ»î»¯£¬£¬£¬´Ó¶øÔÚ·´À¡»ØÂ·ÖÐÒÖÖÆË³²¬ÓÕµ¼µÄNOX4¼¤»î£¬£¬£¬Ôö½ø²¬ÀàÒ©ÎïɱÉËÏÂϸ°ûÄÚµÄÑõ»¯»¹Ô̬µÄÔÙÆ½ºâ¡£Òò´Ë£¬£¬£¬Í¨¹ýROS-CAMK2G-pITPKB -NOX4 µÄÎÈ̬»·Â·£¬£¬£¬Ã»ÓÐɱËÀÂѳ²°©Ï¸°ûµÄ²¬ÀàÒ©Îï¿ÉÄÜʹÂѳ²°©Ï¸°ûÄÍÒ©³Ì¶È±äµÄ¸üÇ¿£¬£¬£¬ROS-CAMK2G-pITPKB-NOX4 ͨ·չÏÖÁËÒ»Öֵ䷶µÄ¹ÌÓÐÒÔ¼°»ñµÃÐÔ²¬ÄÍÒ©µÄ»ìÏý»úÖÆ¡£

ͼʾ£º£º£ºROS-CAMK2G-pITPKB -NOX4 »·Â·Ôö½øÂѳ²°©Ñõ»¯»¹ÔÎÈ̬µÄ×÷ÓûúÖÆÍ¼
±¾ÂÛÎĵÚÒ»×÷ÕßΪngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½Ôº¸¾²ú¿Æ²©Ê¿ºóÀî½à£¬£¬£¬Ë¶Ê¿ÉúÖ£´äÃç¶Ô±¾ÏîÑо¿ÓÐÖ÷ҪТ˳£¬£¬£¬ÖÐɽҽѧԺÅ˳¬ÔƸ±½ÌÊÚÊDZ¾ÎÄͨѶ×÷Õß¡£¸ÃÑо¿»ñµÃÁËngµç×ÓÓÎÏ·ÖÐɽҽѧԺ-Á¥ÊôµÚÒ»Ò½ÔºÏȽøÒ½Ñ§ÊÖÒÕÑо¿ÖÐÐÄ¡¢¹ã¶«Ê¡¶ñÐÔÖ×Áö±í¹ÛÒÅ´«Óë»ùÒòµ÷¿ØÖصãʵÑéÊÒ¿ª·ÅÏîÄ¿¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÒÔ¼°¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðµÈÖ§³Ö¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.nature.com/articles/s41388-021-02149-x